Stockscreener 앱 받기
0.8221
0.37%
0.003
시간 외 거래:
.82
-0.0021
-0.26%
전일 마감가:
$0.8191
열려 있는:
$0.85
하루 거래량:
355.30K
Relative Volume:
0.10
시가총액:
$195.15M
수익:
-
순이익/손실:
$-14.33M
주가수익비율:
-1.2456
EPS:
-0.66
순현금흐름:
$-13.21M
1주 성능:
+16.91%
1개월 성능:
-32.06%
6개월 성능:
-32.06%
1년 성능:
-34.23%
1일 변동 폭
$0.8003
$0.86
1주일 범위
$0.7034
$0.86
52주 변동 폭
$0.66
$2.10
엔라이벡스 Stock (ENLV) Company Profile
ENLV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
0.8221 | 194.44M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
엔라이벡스 Stock (ENLV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-02 | 재확인 | H.C. Wainwright | Buy |
엔라이벡스 주식(ENLV)의 최신 뉴스
Enlivex Therapeutics (ENLV) Lists RAIN Token on KuCoin - GuruFocus
Enlivex Lists RAIN Treasury Token on KuCoin to Deepen Liquidity and Market Access - TipRanks
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange - The Manila Times
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Jackson Sun
Enlivex Therapeutics Ltd. (ENLV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Rashi Peripherals Limited Stock a Safe LongTerm Investment Data BreakdownSupport Level Holds & Low Cost Capital Trading - earlytimes.in
Free cash flow per share of Enlivex Therapeutics Ltd. – SWB:1BT - TradingView — Track All Markets
Enlivex Therapeutics (NASDAQ:ENLV) Downgraded by Wall Street Zen to “Strong Sell” - Defense World
Energy Moves: Why Enlivex Therapeutics Ltd. stock could outperform in 2025Market Activity Summary & Fast Gain Stock Trading Tips - Улправда
What valuation multiples suggest for Enlivex Therapeutics Ltd. stockQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - Улправда
Why Enlivex Therapeutics Ltd. stock could outperform in 2025Chart Signals & Advanced Technical Analysis Signals - Улправда
Why hedge funds are buying Enlivex Therapeutics Ltd. stockMarket Trend Summary & Safe Capital Growth Stock Tips - Улправда
Enlivex Calls February 2026 Extraordinary Meeting to Approve Governance Changes and Reverse Share Split - The Globe and Mail
Levels Update: Will Enlivex Therapeutics Ltd. stock deliver consistent dividendsJuly 2025 Snapshot & Weekly High Return Stock Forecasts - Улправда
Enlivex Therapeutics schedules extraordinary general meeting for February By Investing.com - Investing.com Nigeria
Enlivex Therapeutics schedules extraordinary general meeting for February - Investing.com
Enlivex Therapeutics (NASDAQ: ENLV) schedules Extraordinary General Meeting in Israel - Stock Titan
Earnings Beat: Will Enlivex Therapeutics Ltd. stock deliver consistent dividendsQuarterly Growth Report & Fast Exit and Entry Strategy Plans - Улправда
Enlivex Therapeutics Ltd (ENLV) stock: A year of ups and downs - uspostnews.com
Enlivex Therapeutics (ENLV) price target decreased by 30.00% to 7.14 - MSN
Enlivex: A Necessary UpdateThis Is No Longer The Company We Covered In 2022 (NASDAQ:ENLV) - Seeking Alpha
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial
An analyst sees good growth prospects for Enlivex Therapeutics Ltd (ENLV) - setenews.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Enlivex announces fireside chat on RAIN token and Allocetra development - MSN
Enlivex Announces Fireside Chat on RAIN Token and Allocetra Development - TipRanks
Enlivex Therapeutics Ltd. Announces Virtual Fireside Chat to Discuss Digital Asset Strategy and Clinical Development Plans - Quiver Quantitative
Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development - marketscreener.com
How Enlivex Therapeutics Ltd. stock reacts to oil pricesTrade Analysis Report & Expert Verified Stock Movement Alerts - Newser
Can Enlivex Therapeutics Ltd. stock sustain revenue growth2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
Is Enlivex Therapeutics Ltd. stock a safe haven asset2025 Stock Rankings & Weekly Setup with ROI Potential - Newser
Enlivex Therapeutics (ENLV) Stock Analysis Report | Financials & Insights - Benzinga
What analysts say about Enlivex Therapeutics Ltd stockTechnical Breakout Signals & Rapid Profit Growth - earlytimes.in
Enlivex Therapeutics (ENLV) to Release Quarterly Earnings on Friday - Defense World
엔라이벡스 (ENLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):